SinoMab BioScience Ltd. has successfully completed the issuance of new shares under a general mandate. The completion of the share subscription took place after fulfilling the conditions set out in the Subscription Agreements. An aggregate of 112,810,817 new shares were issued, which now represent 9.37% of the total shares. This strategic move has adjusted the shareholdings, with notable stakeholders such as the Apricot Entities, Hainan Haiyao Co., Ltd., and Skytech Technology Limited seeing changes in their respective shareholding percentages. Skytech Technology Limited is wholly owned by Dr. Shui On Leung, the executive director and chairman of SinoMab. The company is focused on advancing its business objectives with the support of these new capital inflows.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.